Detalles de la búsqueda
1.
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5-fluorouracil and leucovorin combination as first- or second-line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial.
Int J Cancer
; 148(10): 2512-2521, 2021 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270911
2.
Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program.
Support Care Cancer
; 28(7): 3313-3322, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31758323
3.
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
Oncology
; 90(2): 69-78, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26771576
4.
Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer.
Oncologist
; 20(3): 243-4, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25637380
5.
Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy.
Oncology
; 88(3): 180-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472499
6.
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.
Oncology
; 89(6): 319-31, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26457979
7.
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
Lancet
; 377(9769): 914-23, 2011 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21376385
8.
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer.
Cancer Med
; 10(7): 2332-2340, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33666378
9.
Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses.
Breast Cancer Res Treat
; 120(3): 613-26, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19513827
10.
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?
Cancer Invest
; 28(2): 195-200, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19968496
11.
Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.
Oncology
; 78(3-4): 205-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20424491
12.
Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.
BMC Cancer
; 10: 648, 2010 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21108799
13.
Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.
Nutr Cancer
; 62(2): 148-53, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20099188
14.
Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial.
Cancer Med
; 9(12): 4148-4159, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32319740
15.
Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
Oncologist
; 13(12): 1235-45, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19091781
16.
Long-term significance (15 years) of pathological complete response after dose-dense neoadjuvant chemotherapy in breast cancer.
Breast J
; 19(4): 448-50, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23750595
17.
Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trial.
Anticancer Res
; 27(4C): 2689-96, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17695434
18.
A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer.
Anticancer Res
; 27(4C): 2779-83, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17695447
19.
Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer.
Clin Breast Cancer
; 7(4): 336-8, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17092402
20.
Sequential addition of an anthracycline-based regimen to docetaxel as neoadjuvant chemotherapy in patients with operable breast cancer.
Clin Breast Cancer
; 7(3): 262-9, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16942644